CORC

浏览/检索结果: 共1条,第1-1条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression 期刊论文
2019, 卷号: 145, 期号: 6, 页码: 1569-1579
作者:  Schuler, Martin;  Tan, Eng-Huat;  O'Byrne, Kenneth;  Zhang, Li;  Boyer, Michael
收藏  |  浏览/下载:20/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace